Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2021-04-12 08:02 am Sale | 13G | AMNEAL PHARMACEUTICALS INC CL AMRX | WELLINGTON MANAGEMENT GROUP LLP | 54,742 0.04% | -13,851,674 (-99.61%) | View |
2021-02-10 3:04 pm Sale | 13G | AMNEAL PHARMACEUTICALS INC CL AMRX | BlackRock Inc. BLK | 7,342,865 4.97% | -63,930 (-0.86%) | View |
2021-02-10 10:30 am Purchase | 13G | AMNEAL PHARMACEUTICALS INC CL AMRX | VANGUARD GROUP INC | 10,982,831 7.44% | 797,756 (+7.83%) | View |
2021-02-03 1:33 pm Sale | 13G | AMNEAL PHARMACEUTICALS INC CL AMRX | WELLINGTON MANAGEMENT GROUP LLP | 13,906,416 9.42% | -1,621,036 (-10.44%) | View |
2021-01-28 5:56 pm Sale | 13G | AMNEAL PHARMACEUTICALS INC CL AMRX | BlackRock Inc. BLK | 7,406,795 5% | -1,987,829 (-21.16%) | View |
2020-02-14 06:59 am Purchase | 13G | AMNEAL PHARMACEUTICALS INC CL AMRX | Fosun International Ltd | 18,407,656 13.7% | 1,969,300 (+11.98%) | View |
2020-02-12 11:01 am Purchase | 13G | AMNEAL PHARMACEUTICALS INC CL AMRX | VANGUARD GROUP INC | 10,185,075 7.59% | 1,080,013 (+11.86%) | View |
2020-02-12 07:23 am Sale | 13G | AMNEAL PHARMACEUTICALS INC CL AMRX | VANGUARD SPECIALIZED FUNDS | 0 0% | -7,242,047 (Position Closed) | View |
2020-02-07 11:12 am Sale | 13G | AMNEAL PHARMACEUTICALS INC CL AMRX | FMR LLC | 367 0% | -7,310,456 (-99.99%) | View |
2020-02-05 11:26 am Purchase | 13G | AMNEAL PHARMACEUTICALS INC CL AMRX | BlackRock Inc. BLK | 9,394,624 7% | 3,340,897 (+55.19%) | View |
2020-01-28 12:05 pm Sale | 13G | AMNEAL PHARMACEUTICALS INC CL AMRX | WELLINGTON MANAGEMENT GROUP LLP | 15,527,452 11.58% | -495,081 (-3.09%) | View |
2019-12-10 2:18 pm Sale | 13G | AMNEAL PHARMACEUTICALS INC CL AMRX | PRICE T ROWE ASSOCIATES INC | 4,426,332 3.3% | -8,643,523 (-66.13%) | View |
2019-09-11 5:14 pm Unchanged | 13D | AMNEAL PHARMACEUTICALS INC CL AMRX | Patel Chirag K. | 21,300,504 14.3% | 0 (Unchanged) | View |
2019-09-10 12:13 pm Sale | 13G | AMNEAL PHARMACEUTICALS INC CL AMRX | PRICE T ROWE ASSOCIATES INC | 13,069,855 10.1% | -6,551,841 (-33.39%) | View |
2019-08-26 5:27 pm Unchanged | 13D | AMNEAL PHARMACEUTICALS INC CL AMRX | Patel Tushar Bhikhubhai | 53,578,209 29.5% | 0 (Unchanged) | View |
2019-08-26 5:27 pm Purchase | 13D | AMNEAL PHARMACEUTICALS INC CL AMRX | Patel Gautam | 30,415,853 19.2% | 31,084 (+0.10%) | View |
2019-08-06 8:39 pm Purchase | 13D | AMNEAL PHARMACEUTICALS INC CL AMRX | Patel Chirag K. | 21,300,504 7.1% | 31,084 (+0.15%) | View |
2019-08-06 8:37 pm Purchase | 13D | AMNEAL PHARMACEUTICALS INC CL AMRX | Patel Chintu | 24,784,336 8.3% | 31,084 (+0.13%) | View |
2019-07-19 4:51 pm Purchase | 13D | AMNEAL PHARMACEUTICALS INC CL AMRX | TPG Group Holdings (SBS) Advisors Inc. | 16,213,367 12.7% | 4,062,420 (+33.43%) | View |